acrolein has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Wang, Y | 1 |
| Dabzadeh, M; Forouzanfar, F; Ghaddaripouri, M; Hajinejad, M; Sahab-Negah, S | 1 |
| Chen, SP; Fuh, JL; Hsu, WC; Liu, TY; Tsou, HH; Wang, HT | 1 |
| Chen, A; Feng, Q; Wu, L; Xu, C; Xu, Y | 1 |
| Borovic, S; Cindric, M; Cipak, A; Jaganjac, M; Poljak-Blazi, M; Schaur, RJ; Uchida, K; Waeg, G; Zarkovic, K; Zarkovic, N | 1 |
| Niwa, T; Taki, K | 1 |
| Alonso-Varona, A; Bilbao, P; Calle, Y; Castro, B; del Olmo, M; Palomares, T | 1 |
1 review(s) available for acrolein and Disease Exacerbation
| Article | Year |
|---|---|
Natural Cinnamaldehyde and Its Derivatives Ameliorate Neuroinflammatory Pathways in Neurodegenerative Diseases.
Topics: Acrolein; Animals; Disease Models, Animal; Disease Progression; Humans; Inflammation; Neurodegenerative Diseases; Neuroprotective Agents | 2020 |
6 other study(ies) available for acrolein and Disease Exacerbation
| Article | Year |
|---|---|
Cinnamaldehyde Attenuates the Progression of Rheumatoid Arthritis through Down-Regulation of PI3K/AKT Signaling Pathway.
Topics: Acrolein; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Disease Progression; Down-Regulation; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2020 |
Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease.
Topics: Acetylcysteine; Acrolein; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Case-Control Studies; Creatinine; Disease Progression; Early Diagnosis; Female; Humans; Male; Middle Aged | 2018 |
Protective Effects of Olive Leaf Extract on Acrolein-Exacerbated Myocardial Infarction via an Endoplasmic Reticulum Stress Pathway.
Topics: Acrolein; Animals; Apoptosis; Biological Products; Biomarkers; Cell Line; Cytoprotection; Disease Progression; Endoplasmic Reticulum Stress; Iridoid Glucosides; Iridoids; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; Particulate Matter; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2018 |
Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.
Topics: Acrolein; Aldehydes; Animals; Cell Membrane; Disease Progression; Fatty Acids, Unsaturated; Granulocytes; Inflammation; Leukocyte Elastase; Lipid Peroxidation; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Respiratory Burst; Tumor Microenvironment | 2012 |
Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease.
Topics: Acrolein; Administration, Oral; Adsorption; Animals; Biomarkers; Carbon; Chronic Disease; Creatinine; Disease Progression; Gastrointestinal Agents; Indican; Kidney Diseases; Male; Oxidative Stress; Oxides; Prognosis; Rats; Rats, Sprague-Dawley | 2007 |
Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
Topics: Acrolein; Alkylation; Animals; Antineoplastic Agents, Alkylating; Biotransformation; Cell Division; Cyclophosphamide; Cysteine; Disease Progression; Drug Interactions; Drug Screening Assays, Antitumor; Female; Glutathione; Leukopenia; Liver Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Prodrugs; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 2000 |